206 related articles for article (PubMed ID: 27741283)
1. Data Mining of Lung Microbiota in Cystic Fibrosis Patients.
Li J; Hao C; Ren L; Xiao Y; Wang J; Qin X
PLoS One; 2016; 11(10):e0164510. PubMed ID: 27741283
[TBL] [Abstract][Full Text] [Related]
2. Individual Patterns of Complexity in Cystic Fibrosis Lung Microbiota, Including Predator Bacteria, over a 1-Year Period.
de Dios Caballero J; Vida R; Cobo M; Máiz L; Suárez L; Galeano J; Baquero F; Cantón R; Del Campo R
mBio; 2017 Sep; 8(5):. PubMed ID: 28951476
[TBL] [Abstract][Full Text] [Related]
3. Divergence of bacterial communities in the lower airways of CF patients in early childhood.
O'Connor JB; Mottlowitz MM; Wagner BD; Boyne KL; Stevens MJ; Robertson CE; Harris JK; Laguna TA
PLoS One; 2021; 16(10):e0257838. PubMed ID: 34613995
[TBL] [Abstract][Full Text] [Related]
4. Different next generation sequencing platforms produce different microbial profiles and diversity in cystic fibrosis sputum.
Hahn A; Sanyal A; Perez GF; Colberg-Poley AM; Campos J; Rose MC; Pérez-Losada M
J Microbiol Methods; 2016 Nov; 130():95-99. PubMed ID: 27609714
[TBL] [Abstract][Full Text] [Related]
5. The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations.
Fodor AA; Klem ER; Gilpin DF; Elborn JS; Boucher RC; Tunney MM; Wolfgang MC
PLoS One; 2012; 7(9):e45001. PubMed ID: 23049765
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Lung Microbiota in Bronchoalveolar Lavage, Protected Brush and Sputum Samples from Subjects with Mild-To-Moderate Cystic Fibrosis Lung Disease.
Hogan DA; Willger SD; Dolben EL; Hampton TH; Stanton BA; Morrison HG; Sogin ML; Czum J; Ashare A
PLoS One; 2016; 11(3):e0149998. PubMed ID: 26943329
[TBL] [Abstract][Full Text] [Related]
7. Decade-long bacterial community dynamics in cystic fibrosis airways.
Zhao J; Schloss PD; Kalikin LM; Carmody LA; Foster BK; Petrosino JF; Cavalcoli JD; VanDevanter DR; Murray S; Li JZ; Young VB; LiPuma JJ
Proc Natl Acad Sci U S A; 2012 Apr; 109(15):5809-14. PubMed ID: 22451929
[TBL] [Abstract][Full Text] [Related]
8. Measures of Cystic Fibrosis Airway Microbiota during Periods of Clinical Stability.
Caverly LJ; Lu J; Carmody LA; Kalikin LM; Shedden K; Opron K; Azar M; Cahalan S; Foster B; VanDevanter DR; Simon RH; LiPuma JJ
Ann Am Thorac Soc; 2019 Dec; 16(12):1534-1542. PubMed ID: 31415187
[No Abstract] [Full Text] [Related]
9. Maintenance tobramycin primarily affects untargeted bacteria in the CF sputum microbiome.
Nelson MT; Wolter DJ; Eng A; Weiss EJ; Vo AT; Brittnacher MJ; Hayden HS; Ravishankar S; Bautista G; Ratjen A; Blackledge M; McNamara S; Nay L; Majors C; Miller SI; Borenstein E; Simon RH; LiPuma JJ; Hoffman LR
Thorax; 2020 Sep; 75(9):780-790. PubMed ID: 32631930
[TBL] [Abstract][Full Text] [Related]
10. Lung function and microbiota diversity in cystic fibrosis.
Cuthbertson L; Walker AW; Oliver AE; Rogers GB; Rivett DW; Hampton TH; Ashare A; Elborn JS; De Soyza A; Carroll MP; Hoffman LR; Lanyon C; Moskowitz SM; O'Toole GA; Parkhill J; Planet PJ; Teneback CC; Tunney MM; Zuckerman JB; Bruce KD; van der Gast CJ
Microbiome; 2020 Apr; 8(1):45. PubMed ID: 32238195
[TBL] [Abstract][Full Text] [Related]
11. The effects of inhaled aztreonam on the cystic fibrosis lung microbiome.
Heirali AA; Workentine ML; Acosta N; Poonja A; Storey DG; Somayaji R; Rabin HR; Whelan FJ; Surette MG; Parkins MD
Microbiome; 2017 May; 5(1):51. PubMed ID: 28476135
[TBL] [Abstract][Full Text] [Related]
12. Upper versus lower airway microbiome and metagenome in children with cystic fibrosis and their correlation with lung inflammation.
Kirst ME; Baker D; Li E; Abu-Hasan M; Wang GP
PLoS One; 2019; 14(9):e0222323. PubMed ID: 31536536
[TBL] [Abstract][Full Text] [Related]
13. The altered gut microbiota in adults with cystic fibrosis.
Burke DG; Fouhy F; Harrison MJ; Rea MC; Cotter PD; O'Sullivan O; Stanton C; Hill C; Shanahan F; Plant BJ; Ross RP
BMC Microbiol; 2017 Mar; 17(1):58. PubMed ID: 28279152
[TBL] [Abstract][Full Text] [Related]
14. Respiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial intervention.
Cuthbertson L; Rogers GB; Walker AW; Oliver A; Green LE; Daniels TW; Carroll MP; Parkhill J; Bruce KD; van der Gast CJ
ISME J; 2016 May; 10(5):1081-91. PubMed ID: 26555248
[TBL] [Abstract][Full Text] [Related]
15. Fluctuations in airway bacterial communities associated with clinical states and disease stages in cystic fibrosis.
Carmody LA; Caverly LJ; Foster BK; Rogers MAM; Kalikin LM; Simon RH; VanDevanter DR; LiPuma JJ
PLoS One; 2018; 13(3):e0194060. PubMed ID: 29522532
[TBL] [Abstract][Full Text] [Related]
16. Changes in airway bacterial communities occur soon after initiation of antibiotic treatment of pulmonary exacerbations in cystic fibrosis.
Carmody LA; Kalikin LM; VanDevanter DR; Li G; Opron K; Simon RH; Caverly LJ; LiPuma JJ
J Cyst Fibros; 2022 Sep; 21(5):766-768. PubMed ID: 35667975
[TBL] [Abstract][Full Text] [Related]
17. Analysis of changes in diversity and abundance of the microbial community in a cystic fibrosis patient over a multiyear period.
Stokell JR; Gharaibeh RZ; Hamp TJ; Zapata MJ; Fodor AA; Steck TR
J Clin Microbiol; 2015 Jan; 53(1):237-47. PubMed ID: 25392361
[TBL] [Abstract][Full Text] [Related]
18. Testing the neutral theory of biodiversity with the microbiome dataset from cystic fibrosis patients.
Huang Q; Wang Y; Xia Y; Li L; Luo J; Xia S; Sun Y; Miao Y; Wang K; Chen Y
Medicine (Baltimore); 2018 Sep; 97(37):e12248. PubMed ID: 30212959
[TBL] [Abstract][Full Text] [Related]
19. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details.
Feigelman R; Kahlert CR; Baty F; Rassouli F; Kleiner RL; Kohler P; Brutsche MH; von Mering C
Microbiome; 2017 Feb; 5(1):20. PubMed ID: 28187782
[TBL] [Abstract][Full Text] [Related]
20. Airway microbiota across age and disease spectrum in cystic fibrosis.
Zemanick ET; Wagner BD; Robertson CE; Ahrens RC; Chmiel JF; Clancy JP; Gibson RL; Harris WT; Kurland G; Laguna TA; McColley SA; McCoy K; Retsch-Bogart G; Sobush KT; Zeitlin PL; Stevens MJ; Accurso FJ; Sagel SD; Harris JK
Eur Respir J; 2017 Nov; 50(5):. PubMed ID: 29146601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]